VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2021 | MicroRNA panel for multiple sclerosis: potential biomarkers?

Bárbara Guerra Leal • 1 Jul 2021
EAN 2021
Multiple Sclerosis and Related Disorders
Diagnostics

Bárbara Guerra Leal, PhD, University of Porto, Porto, Portugal, discusses the potential use of inflammatory microRNAs as biomarkers for predetermining the onset of MS. An initial trial provided positive results, but further testing is required in order to establish its efficacy. This interview took place during the European Academy of Neurology 2021 congress.

More from Bárbara Guerra Leal

2:47
Inflammatory microRNA levels associate with worse disability in MS
Bárbara Guerra Leal • 8 Oct 2021
1:45
Inflammation in epilepsy: cause or consequence?
Bárbara Guerra Leal • 21 May 2020
1:07
Sleep disorders: VDR gene FokI polymorphism
Bárbara Guerra Leal • 21 May 2020
1:15
Interleukin 1B in MS: analysis of a polymorphism in the gene promoter region
Bárbara Guerra Leal • 1 Jul 2021

Related Videos

1:47
Reviewing PIRA in multiple sclerosis
Jaume Sastre-Garriga • 5 Jul 2023
5:33
The impact of MS treatments on PIRA
Jaume Sastre-Garriga • 5 Jul 2023
3:32
The association between neurodegeneration and PIRA in MS
Jaume Sastre-Garriga • 5 Jul 2023
2:31
Biomarkers of chronic inflammation in MS
Celia Oreja-Guevara • 2 Jul 2023
The content of VJNeurology is intended for healthcare professionals